Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials
Open Access
- 30 September 1998
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 32 (3), 695-703
- https://doi.org/10.1016/s0735-1097(98)00297-6
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureThe New England Journal of Medicine, 1996
- Interobserver discordance in the classification of mechanisms of death in studies of heart failureJournal of Cardiac Failure, 1995
- Studies of Left Ventricular Dysfunction (SOLVD)—Rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fractionThe American Journal of Cardiology, 1990
- Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantationThe American Journal of Cardiology, 1990
- Dilated cardiomyopathy: long-term follow-up and predictors of survivalInternational Journal of Cardiology, 1988
- Mode of death in idiopathic dilated cardiomyopathy: A multivariate analysis of prognostic determinantsAmerican Heart Journal, 1988
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionThe New England Journal of Medicine, 1988
- The hemodynamic consequences of cardiac arrhythmias: Evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine modelAmerican Heart Journal, 1983
- The natural history of idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1981
- Significance of the atrial contribution to ventricular fillingThe American Journal of Cardiology, 1965